检索结果 - Ilene Galinsky
- Showing 1 - 20 results of 47
- Go to Next Page
-
1
-
2
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells 由 Julia Etchin, Alla Berezovskaya, Amy Saur Conway, Ilene Galinsky, Richard M. Stone, Erkan Baloglu, William Senapedis, Yosef Landesman, Michael Kauffman, Sharon Shacham, Jean Wang, A. Thomas Look
出版 2016Artigo -
3
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia 由 Patrick Bhola, Brenton G. Mar, R. Coleman Lindsley, Jeremy Ryan, Leah J. Hogdal, Thanh Trang Vo, Daniel J. DeAngelo, Ilene Galinsky, Benjamin L. Ebert, Anthony Letai
出版 2016Artigo -
4
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells 由 Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett, Sophia Adamia, Richard M. Stone, Ilene Galinsky, Andrew L. Kung, James D. Griffin
出版 2008Artigo -
5
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema 由 Matthew Torre, Isaac H. Solomon, Claire L. Sutherland, Sarah Nikiforow, Daniel J. DeAngelo, Richard M. Stone, Henrikas Vaitkevicius, Ilene Galinsky, Robert F. Padera, Nikolaus S. Trede, Sandro Santagata
出版 2018Artigo -
6
Smac mimetics: implications for enhancement of targeted therapies in leukemia 由 Ellen Weisberg, Arghya Ray, Rosemary Barrett, Erik A. Nelson, Amanda L. Christie, Dale Porter, Christopher Straub, Leigh Zawel, John Daley, Suzan Lazo-Kallanian, Richard Stone, Ilene Galinsky, David A. Frank, Andrew L. Kung, James D. Griffin
出版 2010Artigo -
7
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells 由 Ellen Weisberg, Lolita Banerji, Renee D. Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno, Laurence Catley, Jingrui Jiang, Elizabeth Hall–Meyers, Sauveur-Michel Maira, Richard M. Stone, Ilene Galinsky, Edward Fox, Andrew L. Kung, James D. Griffin
出版 2008Artigo -
8
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells 由 Haymanti Bhanot, Mamatha M. Reddy, Atsushi Nonami, Ellen Weisberg, Dennis Bonal, Paul Kirschmeier, Sabrina Salgia, Klaus Podar, Ilene Galinsky, Tirumala Kumar Chowdary, Donna Neuberg, Giovanni Tonon, Richard M. Stone, John M. Asara, James D. Griffin, Martin Sattler
出版 2015Artigo -
9
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 由 Richard M. Stone, Daniel J. DeAngelo, Virginia M. Klimek, Ilene Galinsky, Eli Estey, Stephen D. Nimer, Wilson Grandin, David Lebwohl, Yanfeng Wang, Pamela Cohen, Edward A. Fox, Donna Neuberg, Jennifer Clark, D. Gary Gilliland, James D. Griffin
出版 2004Artigo -
10
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors 由 Mark J. Levis, Patrick A. Brown, B. Douglas Smith, Adam Stine, Rosalyn Pham, Richard M. Stone, Daniel A. DeAngelo, Ilene Galinsky, Frank Giles, Elihu H. Estey, Hagop M. Kantarjian, Pamela Cohen, Yanfeng Wang, Johannes Roesel, Judith E. Karp, Donald Small
出版 2006Artigo -
11
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK i... 由 Ellen Weisberg, Qingsong Liu, Erik A. Nelson, Andrew L. Kung, Amanda L. Christie, Rod T. Bronson, Martin Sattler, Takaomi Sanda, Zheng Zhao, Won Hur, C Mitsiades, R Smith, J F Daley, Richard M. Stone, Ilene Galinsky, J D Griffin, Nathanael S. Gray
出版 2012Artigo -
12
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia 由 Alexandre Puissant, Nina Fenouille, Gabriela Alexe, Yana Pikman, Christopher F. Bassil, Swapnil Mehta, Jinyan Du, Julhash U. Kazi, Frédéric Luciano, Lars Rönnstrand, Andrew L. Kung, Jon C. Aster, Ilene Galinsky, Richard M. Stone, Daniel J. DeAngelo, Michael T. Hemann, Kimberly Stegmaier
出版 2014Artigo -
13
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells 由 Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, Heidi Mills, Li Yin, Hasan Rajabi, Baldev Vasir, Turner Kufe, Katarina Luptakova, Jon Arnason, Caterina Nardella, James D. Levine, Robin Joyce, Ilene Galinsky, Yoram Reiter, Richard M. Stone, Pier Paolo Pandolfi, Donald Küfe, David Avigan
出版 2013Artigo -
14
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia 由 Yana Pikman, Benjamin H. Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L. Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky, Daniel J. DeAngelo, Jennifer Clark, Stephanie J. Lee, Todd R. Golub, Martha Wadleigh, D. Gary Gilliland, Ross L. Levine
出版 2006Artigo -
15
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 由 Arti Hurria, Constance Cirrincione, Hyman B. Muss, Alice B. Kornblith, William T. Barry, Andrew Artz, Linda E. Schmieder, Rafat Ansari, William P. Tew, Douglas Weckstein, Jeffrey Kirshner, Kayo Togawa, Kurt Hansen, Vani Katheria, Richard M. Stone, Ilene Galinsky, John Postiglione, Harvey Jay Cohen
出版 2011Artigo -
16
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax 由 Joan Montero, Jason Stephansky, Tianyu Cai, Gabriel K. Griffin, Lucía Cabal‐Hierro, Katsuhiro Togami, Leah J. Hogdal, Ilene Galinsky, Elizabeth A. Morgan, Jon C. Aster, Matthew S. Davids, Nicole R. LeBoeuf, Richard M. Stone, Marina Konopleva, Naveen Pemmaraju, Anthony Letai, Andrew A. Lane
出版 2016Artigo -
17
Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia 由 Eyal C. Attar, Daniel J. DeAngelo, Jeffrey G. Supko, Ferdinando D’Amato, David Zahrieh, Andres Sirulnik, Martha Wadleigh, Karen K. Ballen, Steve McAfee, Kenneth B. Miller, James D. Levine, Ilene Galinsky, Elizabeth Trehu, David P. Schenkein, Donna Neuberg, Richard M. Stone, Philip C. Amrein
出版 2008Artigo -
18
Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-R... 由 Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo, Ilene Galinsky, Elihu H. Estey, Carlo Lanza, Edward Fox, Gerhard Ehninger, Eric J. Feldman, Gary J. Schiller, Virginia M. Klimek, Stephen D. Nimer, D. Gary Gilliland, Catherine Dutreix, Alice Huntsman-Labed, J. D. Virkus, Francis J. Giles
出版 2010Artigo -
19
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML 由 Jingrui Jiang, J. Guillermo Paez, Jeffrey C. Lee, Ronghai Bo, Richard M. Stone, Daniel J. DeAngelo, Ilene Galinsky, Brian M. Wolpin, Anna Jonášová, Paula Herman, Edward A. Fox, Titus J. Boggon, Michael J. Eck, Ellen Weisberg, James D. Griffin, D. Gary Gilliland, Matthew Meyerson, William R. Sellers
出版 2004Artigo -
20
Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097 由 Ellen Weisberg, Ensar Halilovic, Vesselina G. Cooke, Atsushi Nonami, Tao Ren, Takaomi Sanda, Irene Simkin, Jing Yuan, Brandon Antonakos, Louise Barys, Moriko Ito, Richard M. Stone, Ilene Galinsky, Kristen Cowens, Erik A. Nelson, Martin Sattler, Sébastien Jeay, Jens Wuerthner, Sean M. McDonough, Marion Wiesmann, James D. Griffin
出版 2015Artigo
相关主题
Biology
Cancer research
Leukemia
Medicine
Myeloid leukemia
Immunology
Genetics
Internal medicine
Biochemistry
Cancer
Gene
Cell biology
Myeloid
Tyrosine kinase
Oncology
Signal transduction
Chemistry
Apoptosis
Pharmacology
Stem cell
Tyrosine-kinase inhibitor
Bone marrow
Computational biology
Cell growth
Chemotherapy
Chronic lymphocytic leukemia
Disease
Fms-Like Tyrosine Kinase 3
Gene expression
Haematopoiesis